Ameriprise’s Zoetis ZTS Stock Holding History

Ameriprise’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19,500	Closed	-$3.04M	–	4198
2025 Q2	$3.04M	Buy	+19,500	New	+$3.09M	﹤0.01%	2709

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameriprise's ZTS Position: Q1 2026 in Review

Ameriprise reduced its Zoetis (ZTS) stake by 17% in Q1 2026, selling an estimated $40.3M and leaving 1,610,634 shares worth $190M. The position accounts for 0.04% of the portfolio, ranked #381.

Ameriprise first reported a position in ZTS in Q2 2013 and has held it in 52 quarters since. The position peaked at $712M in Q1 2024. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

Ameriprise held 1,610,634 shares of Zoetis worth $190M as of Q1 2026.
Ameriprise sold 326,297 Zoetis shares in Q1 2026, an estimated $40.3M.
Zoetis made up 0.04% of Ameriprise's portfolio in Q1 2026, its #381 holding.
Ameriprise first reported a position in Zoetis in Q2 2013 and has held it in 52 quarters since.
Ameriprise's Zoetis position peaked at $712M in Q1 2024.
1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.